Week 3: Hyperthyroidism Flashcards
1
Q
Etiologies of hyperthyroidism, based on elevated or suppressed RAIU
A
- Elevated RAIU (radioactive iodine uptake)
- Graves’ disease
- toxic multinodular goiter
- toxic adenoma
- TSH secreting pituitary tumor
- hydatidform mole
- choriocarcinoma - Suppressed RAIU
- exogenous T4/T3
- subacute thyroiditis
- postpartum thyroiditis
- painless thyroiditis
- exogenous iodides
- radiation thyroiditis
- metastatic follicular cancer
- struma ovari
2
Q
Metabolic adaptation to hyperthyroidism
A
- increase in O2 consumption and heat generation (increase basal metabolic rate)
- increase in Na/K ATPase activity
- fatty acid turnover
- myosin and Ca ATPase activity
- increase number and sensitivity of beta adrenergic response - increase heart rate and cardiac output
- b1 and T3 - peripheral vasodilation
- b2 and T3
3
Q
Symptoms of hyperthyroidism
A
- nervousness and anxiety
- heat intolerance and sweating
- increase appetite and weight loss
- palpitations and SOB
- muscle weakness
- easy fatiguability
- sleep disturbance
- increase frequency of bowel movements
4
Q
Signs of hyperthyroidism
A
- restless and rapid rate of speech
- warm, moist, smooth skin
- dynamic precordium with supra ventricular arrhythmias
- muscle weakness
- fine tremors
- widened pulse pressure
- examine for eye disease (graves): bulging eyes, EOM-inferior and media rectus dysfxn, conjunctivitis, edema
- examine for pretibial myxedema
5
Q
epidemiology and Pathophysiology of grave’s disease
A
- 5:1 female to male, usually around reproductive years
- genetic predisposition ( HLA-DR3 and HLA B8), and inciting event leads to thyroid injury
- thyroid expresses class II antigens on cell surface. abnormal antigen presentation on follicular cell precipitates immune response and production of IgG. Th2 dominant response.
- TSI: thyroid stimulating immunoglobulini binds to and stimulates TSH receptor, producing glandular growth and excess secretion of T3
- -leads to hyperthyroidism, pretibial myxedema, and opthalmopathy
6
Q
Features of Grave’s Disease
A
- Goiter, usually hyperthyroid
- Opthalmopathy
- Pretibial myxedema (infiltrative dermopathy)
7
Q
Pathogenesis of Graves’ opthalmopathy
A
- orbital preadipocytes mature into adipocytes that express TSH receptors
- increase in orbital fatty tissue
- activated T cells within orbit react with local TSH receptors to produce cytokines
- g-INF, TNF-b, Il-1b stimulate glycosaminoglycan deposition as well as fibroblast proliferation
- leads to proptosis, EOM enlargement and dysfunction, periorbital congestion
8
Q
Laboratory findings in Graves’ disease
A
- elevated T4 and T3 (T3: T4 is 20:1)
- suppressed TSH levels (<0.01)
- positive anti-TPO antibody.
- RAIU elevated with diffuse uptake
9
Q
Therapy of hyperthyroidism
A
- Acute
- block thyroid hormone synthesis with thioamide drugs (PTU and methimazole/tapazole)
- reduce adrenergic symptoms with beta blocker: propranolol or atenolol (selective) - Chronic
- long term remission with anti-thyroid drugs in up to 50% of patients
- 131I ablation
- surgery
10
Q
Antithyroid drugs
A
- treat 12-18months
- repeat TFTs in 6-8 weeks after start. If patient is compliment, should take no more than 4 months of therapy
1. Methimazole (MMI) - inhibits thyroid peroxidase
- no effect on T4 to T3
- one a day dosing
- use this first unless pregnant (PTU drug of choice in first trimester), or allergic
2. Propylthiouracil (PTU) - inhibits thyroid peroxidase
- inhibits T4 to T3 mediated by type 1 5’-deiodinase
- 2-3x daily
11
Q
Adverse effects with PTU and MMI
A
- skin reaction
- cholestatic hepatitis
- agranulocytosis: if fever and sore throat, do CBC
- pregnancy: both can cross placenta and can depress fetal thyroid gland, don’t use in first trimester.
12
Q
Other treatments for Graves with failure of antithyroid medications
A
- Radioactive iodide
- indications: unlikely to remit with thionamides, allergy to thionamides, lack of patience
- avoid during pregnancy - Surgery
13
Q
Subacute thyroiditis
A
- etiology: viral, associated with HLA Bw35
- symptoms: viral symptoms, tender thyroid, thyrotoxicosis,
- low RAIU, elevated T3, T4, suppressed serum TSH
- Rx: beta blockers for symptoms. No role for anti thyroid drugs. NSAIDs, oral corticosteroids, L-T4 during hypothyroid phase
14
Q
Pattern of illness for subacute thyroiditis
A
- 0-4 weeks: hyperthyroid phase
- 4-12 weeks: hypothyroid phase: decreased T4, elevated TSH, variable RAIU
- 12+ weeks: recovery phase. Normal thyroid function
15
Q
Post partum thyroiditis
A
- 8% in US
- autoimmune pathogenesis, associated with HLA B,D
- patients with Type 1 DM, hx of autoimmune disease are at highest risk
- presents with hypothyroid, hyperthyroid, or both. May or may not have goiter
- Rx with beta blocker
- 20% will remain permanently hypothyroid with any episode